Syneos Health, Inc. - (SYNH): Price and Financial Metrics


Syneos Health, Inc. - (SYNH): $70.91

1.14 (+1.63%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SYNH POWR Grades


  • Growth is the dimension where SYNH ranks best; there it ranks ahead of 99.27% of US stocks.
  • SYNH's strongest trending metric is Quality; it's been moving down over the last 179 days.
  • SYNH ranks lowest in Quality; there it ranks in the 24th percentile.

SYNH Stock Summary

  • SYNH has a market capitalization of $8,609,708,210 -- more than approximately 79.52% of US stocks.
  • With a one year PEG ratio of 108.51, Syneos Health Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 79.59% of US stocks.
  • SYNH's current price/earnings ratio is 36.66, which is higher than 78.03% of US stocks with positive earnings.
  • If you're looking for stocks that are quantitatively similar to Syneos Health Inc, a group of peers worth examining would be ACHC, FLT, RUTH, CGC, and FRGI.
  • SYNH's SEC filings can be seen here. And to visit Syneos Health Inc's official web site, go to www.syneoshealth.com.

SYNH Valuation Summary

  • SYNH's price/earnings ratio is 40.7; this is 11.51% higher than that of the median Healthcare stock.
  • SYNH's price/sales ratio has moved up 0.8 over the prior 83 months.
  • SYNH's price/earnings ratio has moved up 70 over the prior 83 months.

Below are key valuation metrics over time for SYNH.

Stock Date P/S P/B P/E EV/EBIT
SYNH 2021-08-31 2 3.0 40.7 36.6
SYNH 2021-08-30 2 3.0 41.0 36.8
SYNH 2021-08-27 2 2.9 40.3 36.4
SYNH 2021-08-26 2 2.9 40.0 36.1
SYNH 2021-08-25 2 2.9 39.9 36.1
SYNH 2021-08-24 2 2.9 39.4 35.7

SYNH Growth Metrics

    The 4 year price growth rate now stands at 17.58%.
  • Its 2 year net income to common stockholders growth rate is now at 205.77%.
  • Its 3 year cash and equivalents growth rate is now at 101.13%.
Over the past 34 months, SYNH's revenue has gone up $761,044,000.

The table below shows SYNH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 5,212.97 450.278 234.831
2021-09-30 4,979.605 378.625 250.758
2021-06-30 4,730.379 486.123 235.931
2021-03-31 4,461.167 591.188 197.937
2020-12-31 4,415.777 425.493 192.787
2020-09-30 4,488.712 471.715 191.951

SYNH's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SYNH has a Quality Grade of D, ranking ahead of 21.57% of graded US stocks.
  • SYNH's asset turnover comes in at 0.618 -- ranking 262nd of 563 Business Services stocks.
  • INS, HURN, and MEDP are the stocks whose asset turnover ratios are most correlated with SYNH.

The table below shows SYNH's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.618 0.233 0.100
2021-06-30 0.602 0.238 0.096
2021-03-31 0.579 0.234 0.085
2020-12-31 0.580 0.230 0.083
2020-09-30 0.602 0.225 0.067
2020-06-30 0.612 0.218 0.070

SYNH Price Target

For more insight on analysts targets of SYNH, see our SYNH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $80.92 Average Broker Recommendation 1.33 (Strong Buy)

SYNH Stock Price Chart Interactive Chart >

Price chart for SYNH

SYNH Price/Volume Stats

Current price $70.91 52-week high $104.18
Prev. close $69.77 52-week low $66.73
Day low $68.98 Volume 425,700
Day high $71.34 Avg. volume 713,957
50-day MA $76.56 Dividend yield N/A
200-day MA $87.97 Market Cap 7.27B

Syneos Health, Inc. - (SYNH) Company Bio


Syneos Health, formerly INC Research Holdings, provide the full range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The company was founded in 2010 and is based in Raleigh, North Carolina.


SYNH Latest News Stream


Event/Time News Detail
Loading, please wait...

SYNH Latest Social Stream


Loading social stream, please wait...

View Full SYNH Social Stream

Latest SYNH News From Around the Web

Below are the latest news stories about Syneos Health Inc that investors may wish to consider to help them evaluate SYNH as an investment opportunity.

Syneos Health, Inc. 2021 Q4 - Results - Earnings Call Presentation

No summary available.

Seeking Alpha | February 18, 2022

Syneos Health (SYNH) Q4 Earnings Top Estimates, Margins Down

Syneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms.

Yahoo | February 18, 2022

Syneos Health Inc. (SYNH) CEO Alistair Macdonald on Q4 2021 Results - Earnings Call Transcript

Syneos Health Inc. (SYNH) Q4 2021 Results Conference Call February 17, 2022 08:00 AM ET Company Participants Ronnie Speight - SVP, Investor Relations Alistair Macdonald - Chief Executive Officer Jason Meggs - Chief Financial Officer Michael Brooks - Chief Development Officer & Global Head, Clinical Development Solutions Conference Call Participants...

SA Transcripts on Seeking Alpha | February 17, 2022

Triangle’s Syneos Health tops Street earnings due to ‘strong fundamentals,’ CEO says | WRAL TechWire

Syneos Health on Thursday morning reported fourth-quarter profit of $76 million, and its CEO cited "strong fundamentals" for a report that beats on earnings despite a slight miss on revenue forecasts.

WRAL TechWire | February 17, 2022

Syneos Health tops Street earnings due to ‘strong fundamentals,’ CEO says | WRAL TechWire

Syneos Health on Thursday morning reported fourth-quarter profit of $76 million, and its CEO cited "strong fundamentals" for a report that beats on earnings despite a slight miss on revenue forecasts.

WRAL TechWire | February 17, 2022

Read More 'SYNH' Stories Here

SYNH Price Returns

1-mo -11.13%
3-mo -10.23%
6-mo -29.90%
1-year -18.61%
3-year 68.19%
5-year 26.17%
YTD -30.94%
2021 50.71%
2020 14.55%
2019 51.14%
2018 -9.75%
2017 -17.11%

Continue Researching SYNH

Want to see what other sources are saying about Syneos Health Inc's financials and stock price? Try the links below:

Syneos Health Inc (SYNH) Stock Price | Nasdaq
Syneos Health Inc (SYNH) Stock Quote, History and News - Yahoo Finance
Syneos Health Inc (SYNH) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7725 seconds.